Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06315166Not ApplicableActive Not Recruiting

Study on Using Radiofrequency to Treat Moderate to Severe Acne

Role: lead

NCT01858415Not ApplicableUnknown

Evaluation of Safety and Efficacy of TriPollar Device for Treatment of Wrinkles

Role: lead

NCT01283711Not ApplicableCompleted

Evaluation of Safety and Efficacy of the Apollo™ System for Treatment of Wrinkles and Rhytides

Role: lead

NCT01566396Not ApplicableCompleted

Evaluation of Safety and Efficacy of the 3F Applicator (A3F) for Treatment of Facial Wrinkles

Role: lead

All 4 trials loaded